Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Cadila Shifts US Injectables Production From Plant After Tough FDA Inspection
Nov 15 2019
•
By
Bowman Cox
inspection raised concerns
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Compliance
More from Pink Sheet